Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Completed 6Terminated 3Recruiting 3Active not recruiting 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Smoking Cessation 2Tobacco Use Disorder 1Tobacco Smoking 1Substance-Related Disorders 1Cigarette Smoking-Related Carcinoma 1

Interventions

Specimen Handling 336Magnetic Resonance Spectroscopy 333Radiotherapy 315Cyclophosphamide 295pembrolizumab 282Cisplatin 266Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 206Bevacizumab 187Gemcitabine 177venetoclax 172Radiosurgery 169Capecitabine 165Oxaliplatin 163fludarabine 160Nivolumab 156Paclitaxel 155Standard of Care 137Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 127Fluorouracil 125Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104atezolizumab 101Azacitidine 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × OTHER × Nicotine Replacement Therapy × Clear all
NCT05515354 2026-03-19

MC-NRT

Centre for Addiction and Mental Health

Phase 4 Recruiting
1,200 enrolled

Tobacco Smoking, Tobacco Use Disorder, Smoking Cessation, Substance-Related Disorders

NCT06290869 2026-02-17

TEAL

Georgetown University

Phase 3 Recruiting
1,188 enrolled

Smoking Cessation

NCT06763536 2025-06-22

ARISE

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
1,000 enrolled

Cigarette Smoking-Related Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡